A Transforming Growth Factorβ1 Signal Peptide Variant Increases Secretion in Vitro and Is Associated with Increased Incidence of Invasive Breast Cancer
暂无分享,去创建一个
J. Chang-Claude | B. Ponder | D. Easton | P. Pharoah | A. Dunning | R. Luben | C. Healey | A. Mannermaa | V. Kataja | J. Metcalfe | H. L. Kirschenlohr | S. McBride | P. Kemp | P. D. Ellis
[1] J. Chang-Claude,et al. Breastfeeding and breast cancer risk by age 50 among women in Germany , 2000, Cancer Causes & Control.
[2] R. Dickson,et al. Growth Factors, Apoptosis, and Survival of Mammary Epithelial Cells , 1999, Journal of Mammary Gland Biology and Neoplasia.
[3] S. Sato,et al. Transforming growth factor β1 gene polymorphism in rheumatoid arthritis , 2002, Annals of the rheumatic diseases.
[4] R. Madhok,et al. Analysis of transforming growth factor β1 gene polymorphisms in patients with systemic sclerosis , 2002, Annals of the rheumatic diseases.
[5] A. Balmain,et al. Metastasis is driven by sequential elevation of H-ras and Smad2 levels , 2002, Nature Cell Biology.
[6] F. Ando,et al. Association of a polymorphism of the transforming growth factor-β1 gene with blood pressure in Japanese individuals , 2002, Journal of Human Genetics.
[7] M. Goumans,et al. Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.
[8] A. Gressner,et al. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[9] J. Downward,et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis , 2002, The Journal of Cell Biology.
[10] David L Rimm,et al. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. , 2002, Cancer research.
[11] N E Day,et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes , 2002, British Journal of Cancer.
[12] J. Downward,et al. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. , 2002, The Journal of cell biology.
[13] I. Adcock,et al. TGFβ1 allele association with asthma severity , 2001, Human Genetics.
[14] C. Bouchard,et al. TGF-β1 gene-race interactions for resting and exercise blood pressure in the HERITAGE family study , 2001 .
[15] W. Weimar,et al. TGF-β1 gene polymorphisms in patients with end-stage heart failure , 2001 .
[16] N E Day,et al. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study , 2001, Genetic epidemiology.
[17] E. Ziv,et al. Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures. , 2001, JAMA.
[18] D. Kang,et al. Polymorphic catechol-O-methyltransferase gene and breast cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] W. Weimar,et al. THE TRANSFORMING GROWTH FACTOR-&bgr;1 CODON 10 GENE POLYMORPHISM AND ACCELERATED GRAFT VASCULAR DISEASE AFTER CLINICAL HEART TRANSPLANTATION , 2001, Transplantation.
[20] A. Schulze,et al. Analysis of the transcriptional program induced by Raf in epithelial cells , 2001, Nature Genetics.
[21] P. Simpson,et al. Statistical methods in cancer research , 2001, Journal of surgical oncology.
[22] W. Weimar,et al. TGF-beta1 gene polymorphisms in patients with end-stage heart failure. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[23] O. Viklicky,et al. TGF-beta I gene polymorphism in heart transplant recipients--effect on renal function. , 2001, Annals of transplantation.
[24] R. Hesketh,et al. Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer. , 2001, Cancer research.
[25] A. Balmain,et al. TGF-beta signaling in tumor suppression and cancer progression. , 2001, Nature genetics.
[26] I. Adcock,et al. TGFbeta1 allele association with asthma severity. , 2001, Human genetics.
[27] C. Bouchard,et al. TGF-beta(1) gene-race interactions for resting and exercise blood pressure in the HERITAGE Family Study. , 2001, Journal of applied physiology.
[28] A. Schulze,et al. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. , 2000, Genes & development.
[29] Yoshiji Yamada,et al. Association of a Leu10→Pro polymorphism of the transforming growth factor-β1 with genetic susceptibility to osteoporosis and spinal osteoarthritis , 2000, Mechanisms of Ageing and Development.
[30] M. Yokota,et al. Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. , 2000, Circulation.
[31] L. Wakefield,et al. Transforming growth factor-β and breast cancer: Lessons learned from genetically altered mouse models , 2000, Breast Cancer Research.
[32] S. Markowitz. TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. , 2000, Biochimica et biophysica acta.
[33] Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases , 2000 .
[34] H. Friess,et al. The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer , 1999, Oncogene.
[35] N. Day,et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.
[36] M. Rothmund,et al. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors , 1999, Oncogene.
[37] K. Kinzler,et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. , 1999, Cancer research.
[38] T. Spector,et al. Genetic control of the circulating concentration of transforming growth factor type beta1. , 1999, Human molecular genetics.
[39] H. Friess,et al. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. , 1999, Oncogene.
[40] J. Gunn,et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. , 1998, Clinical science.
[41] J. Gunn,et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. , 1998, Clinical science.
[42] M. Reiss,et al. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. , 1998, Cancer research.
[43] M. Reiss,et al. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. , 1998, Cancer research.
[44] Julian Peto,et al. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.
[45] N. Day,et al. Family history and the risk of breast cancer: A systematic review and meta‐analysis , 1997, International journal of cancer.
[46] D. Arveiler,et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. , 1996, Hypertension.
[47] J. Bartlett,et al. Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy. , 1996, British Journal of Cancer.
[48] Julian Peto,et al. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.
[49] M. Sporn,et al. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. , 1992, Cancer research.
[50] A G Babiker,et al. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.